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ABSTRACT: Effects of altering the properties of an active site in an enzymatic homogeneous catalyst have been extensive-
ly reported. However the possibility of increasing the number of such sites, as commonly done in heterogeneous catalytic 
materials, remains unexplored, particularly because those have to accommodate appropriate residues in specific configu-
rations. This possibility was investigated by using a serine ester hydrolase as the target enzyme. By using the Protein En-
ergy Landscape Exploration software, which maps ligand diffusion and binding, we found a potential binding pocket ca-
pable of holding an extra catalytic triad and oxyanion hole contacts. By introducing two mutations, this binding pocket 
became a catalytic site. Its substrate specificity, substrate preference and catalytic activity were different to those of the 
native site of the wild type ester hydrolase and other hydrolases, due to the differences in the active site architecture. 
Converting the binding pocket into an extra catalytic active site was proven a successful approach to create a serine ester 
hydrolase with two functional reactive groups. Our results illustrate the accuracy and predictive nature of modern model-
ing techniques, opening novel catalytic opportunities coming from the presence of different catalytic environments in 
single enzymes. 
INTRODUCTION 
A number of studies have shown the utility of placing 
multiple functional groups randomly or uniformly on the 
surface of solid heterogeneous catalysts to enhance activi-
ty and selectivity.1 Functional groups are positioned in 
those catalysts at varying distances and spatial arrange-
ments. However, these advances have not been as well 
developed for enzymatic catalysts. Thus, with few excep-
tions,2-4 all enzymes contain one active site. Although 
introducing single active sites into non-catalytic proteins 
has been successfully achieved,5-16 no evidence has been 
gathered that demonstrates that introducing a second or 
more active sites into an enzyme is feasible. If one could 
use molecular modeling to discover extra binding pockets 
and convert them into catalytic sites, then one would 
facilitate designing enzymes with multiple reactive 
groups. This would promote the competitiveness and 
catalytic opportunities of enzymes coming from different 
catalytic environments, and be a considerable step for-
ward in the field of de novo enzyme design. 
We tested this hypothesis by using a serine ester hydro-
lase from the structural superfamily of α/β-hydrolases as a 
model enzyme. The activity of serine ester hydrolases 
relies mainly on a catalytic triad usually formed by Ser, 
Asp/Glu and His.17 The initial attack of an ester is mediat-
ed by the Ser residue that acts as nucleophile through 
which a covalent intermediate is formed in collaboration 
with two other residues (Asp and His) that help activate 
the nucleophile by forming a charge-relay network. At 
basic pH the His residues are δ-protonated, and the Asp 
residues are deprotonated, resulting in the formation of a 
His-Ser and His-Asp hydrogen-bonding network. The 
stabilization of the intermediate is increased by so-called 
oxyanion hole contacts with nitrogen atoms of adjacent 
Gly residues.17 
This enzyme class was selected for a number of reasons. 
First, it is widely distributed in the environment, it has 
important physiological functions, it includes hydrolases 
which are among the most important industrial biocata-
lysts, and extensive biochemical knowledge has been 
accumulated.18 Second, a number of studies have dis-
closed the utility of computational tools to introduce 
active sites supporting ester hydrolysis in a number of 
non-catalytic proteins. A first attempt used RosettaMatch 
to search for catalytically inert theozyme scaffold proteins 
that could accommodate a model catalytic triad (Cys-His-
 Glu/Asp) and oxyanion holes reassembling cysteine-like 
geometries.11 Authors identified 4 protein scaffolds with 
minimalistic catalytic schema consisting of a Cys nucleo-
phile, a nearby His and a backbone NH group, which were 
capable of hydrolyzing the model esters coumarin-(2-
phenyl)-propanoate and a p-nitrophenyl-(2-phenyl)-
propanoate (pN2PP) (k2/KS up to 309 M-1s-1). More recent-
ly, Moroz and colleagues took advantage of existing en-
zymatic folds to explore whether calmodulin (CaM) could 
assume esterase activity against pN2PP.16 Docking was 
used to determine whether pN2PP accommodates into a 
hydrophobic cavity of CaM. Residues facing the substrate 
were then identified and further mutated to His, a residue 
that, per se, has been shown to catalyze hydrolysis of 
pN2PP, albeit with a modest activity. A mutant with a 
single Met144His substitution was capable of hydrolyzing 
pN2PP (kcat/KM up to 4800 M-1min-1). In another approach, 
the hydrolysis of p-nitrophenyl acetate (pNPA) was 
achieved by incorporating mutations favoring metal bind-
ing, with the metal being the catalytic component. By 
using this approach, Zn2+ and/or Hg2+ ions were intro-
duced into the Rab-4-binding domain,10 the TRI family of 
peptides,12 and short amyloid-forming peptides.14 The 
resulting metallo-proteins were capable of pNPA hydroly-
sis (kcat/KM up to 630, 23.3 and 18 M-1s-1). The question of 
where to put the functional group has been found to be 
critical for catalytic performance. For example, it has been 
demonstrated that the His orientation modulates local 
metal orientation, which in turn has functional conse-
quences.19,20   
It remains to be established whether the computational 
approaches described above can be implemented to in-
troduce multiple active sites supporting ester hydrolysis, 
not only in non-catalytic proteins but also in ester hydro-
lases already containing a native functional group. The 
novelty of this study relies on using the Protein Energy 
Landscape Exploration (PELE) software. PELE offers one 
of the best modeling alternatives to map protein-ligand 
dynamics and induced fit.21-25 It allows for a complete 
protein surface exploration, locating binding site pockets 
in only few hours of a moderate computing cluster (~32 
computing cores).26,27 Thus, these technological develop-
ments are ideally suited to locate, without previous 
knowledge, potential binding sites that could be convert-
ed into active sites. Finding these pockets typically re-
quires significant enzyme reorganization, both at the level 
of conformational sampling and induced fit.27 Thus, simi-
lar analysis cannot be performed with simple docking 
techniques. Effective alternative techniques are mostly 
limited to molecular dynamic simulations,28 although at a 
significantly higher computational cost.  
The present study adds important insights and empiri-
cal and computational data proving, for first time to the 
best of our knowledge, that introducing extra catalytic 
reactive groups into a serine ester hydrolase is plausible. 
We would like to highlight that our approach is based on 
locating, by PELE software, extra binding pockets and 
converting them into catalytic active sites. We were inter-
ested not only in proving that introducing extra function-
al groups into a catalytic serine ester hydrolase is plausi-
ble, but also in examining the catalytic potential of the 
resulting variant compared to the wild type enzyme and 
other native ester hydrolases. In this line, we have unam-
biguously confirmed that the extra catalytic site is not 
only competitive with those of other native ester hydro-
lases, but also could confer catalytic changes when intro-
duced in the wild type ester hydrolase already containing 
a native active site. 
 
EXPERIMENTAL AND COMPUTATIONAL METHODS 
Chemicals and oligonucleotides. All chemicals used 
for enzymatic tests were of the purest grade available and 
were purchased from Sigma Chemical Co. (St Louis, MO, 
USA), Alfa Aesar (Karlsruhe, Germany) or Santa Cruz 
Biotechnology (Heidelberg, Germany). The oligonucleo-
tides used for DNA amplification were synthesized by 
Sigma Genosys Ltd. (Pampisford, Cambs, UK). 
EH1A protein source and crystal structure. The isola-
tion of the enzyme EH1A used in the present study was 
reported previously.29 The enzyme is available in the ex-
pression vector pET46 Ek/LIC plasmid and Escherichia 
coli BL21 as a host,29,30 which was the source of the en-
zyme for the present study. The crystal structure of EH1A 
protein was recently solved (PDB code: 5JD4) and X-ray 
diffraction data collection and refinement statistics are 
available.30 
Site directed mutagenesis. Mutagenic PCR was devel-
oped using the Quick Change Lightning Multi Site-
Directed Mutagenesis kit (Agilent Technologies, Cheadle, 
UK), following manufacturer instructions. Briefly, 50 ng 
of pET46 Ek/LIC plasmid containing wild type EH1A DNA 
insert was mixed with a master mix containing 2.5 µl of 
10x Multireaction buffer, 0.5 µl of Quick solution, 1 µl of 
dNTP mix, 1 µl of Multy enzyme blend and 100 ng of each 
primer. Distilled water was added to a final volume of 25 
µl. PCR conditions were as follow:  2 minutes at 95ºC, 30 
cyles of 20 seconds at 95ºC, 30 seconds at 55ºC, 195 sec-
onds at 65ºC, and one cycle of 5 minutes at 65ºC. The 
resulting variant plasmids were transferred into E. coli 
BL21 and selected on the Luria Bertani (LB) agar supple-
mented with 50 µg ml-1 ampicillin. To obtain the variant 
EH1B, the following primers were used: Ser161Ala Fwd 
(GTG GGC GGC GAT GCG GCG GGC GGC G), Glu25Asp 
Fwd (CGG CCC CGG CTG GAT ACC CTG CCG CAT GC) 
and Leu214His Fwd (TTC CTC AGC AAG GCG CAC ATG 
GAC TGG TTC TGG G). To obtain the variant EH1AB, only 
the primers Glu25Asp Fwd and Ile214His Fwd were used.  
To obtain variants containing Ser211Ala, Ser161Ala, 
Asp25Gln, Asp256Gln, His214Phe and His286Phe muta-
tions, individually or in combination, the pET46 Ek/LIC 
plasmid containing EH1A, EH1B, or EH1AB DNA inserts and 
the primers Ser211Ala Fwd (GCC GAA GGC TAC TTC CTC 
GCC AAG GCG CAC ATG GAC TGG), Ser161Ala Fwd (GTG 
GGC GGC GAT GCG GCG GGC GGC G), Asp25Gln Fwd 
(CGG CCC CGG CTG CAG ACC CTG CCG CAT GC), 
Asp256Gln Fwd (ACC GCC GGC TAC CAA CCG CTG CGC 
GAC G), His214Phe Fwd (TTC CTC AGC AAG GCG TTC 
 ATG GAC TGG TTC TGG G) and His286Phe Fwd (T CCC 
GGC ACC ATC TTC GGC TTC TTC TCG), were used. 
Mutagenic PCR conditions were as above. 
Gene expression and protein purification. Protein 
expression and purification of wild type and mutants were 
performed as previously described with slight modifica-
tions.29,30 Briefly, selected E. coli clones that expressed 
each protein, His-tagged at the N-terminus, were grown 
at 37 °C on solid LB agar medium supplemented with 50 
µg ml-1 ampicillin, and one colony was picked and used to 
inoculate 10 ml of LB broth plus antibiotic in a 0.25-l flask. 
The cultures were then incubated at 37 °C and 200 rpm 
overnight. Afterward, 10 ml of this culture was used to 
inoculate 0.5 liter of LB medium, which was then incu-
bated to an OD600nm to approximately 0.7 (ranging from 
0.55 to 0.75) at 37 °C. Protein expression was induced by 
adding isopropyl β-D-1-thiogalactopyranoside to a final 
concentration of approx. 1 mM, followed by incubation for 
16 h at 16 °C. The cells were harvested by centrifugation at 
5000 × g for 15 min to yield a pellet of 2-3 g l-1 pellet (wet 
weight). The wet cell pellet was frozen at -86 °C over-
night, thawed and resuspended in 15 ml of 40 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 
pH 7.0. Lysonase Bioprocessing Reagent (Novagen, Darm-
stadt, Germany) was added (4 µl g-1 wet cells) and incu-
bated for 60 min on ice with rotating mixing. The cell 
suspension was sonicated using a pin Sonicator® 3000 
(Misonix, New Highway Farmingdale, NY, USA) for a 
total time of 5 min (10 W) on ice and centrifuged at 15000 
× g for 15 min at 4°C, and the supernatant was retained.  
The His-tagged proteins, native and engineered vari-
ants, were purified at 4 °C after binding to a Ni-NTA His-
Bind resin (Sigma Chemical Co. (St Louis, MO, USA)), 
followed by ultra-filtration through low-adsorption hy-
drophilic 10000 nominal molecular weight limit cutoff 
membranes (regenerated cellulose, Amicon) to concen-
trate the protein solution. An extensive dialysis of protein 
solutions against 40 mM HEPES buffer (pH 7.0) was then 
performed using Pur-A-LyzerTM Maxi 1200 dialysis kit 
((Sigma Chemical Co. (St Louis, MO, USA)), as follows. 
Five ml concentrated protein solution was dialyzed 
against 2 L buffer during 1 hour at room temperature, 
after which the buffer was changed by other 2 L buffer 
and maintained 1 hour more. Then, the buffer was 
changed and the dialysis was kept overnight at 4ºC. The 
dialyzed protein solution was recovered and concentrated 
as before. The concentrated protein solution (10 mg ml-1) 
was then subjected to size-exclusion chromatography by a 
fast protein liquid chromatography (FPLC) equipment 
(LCC-500CI, Amersham Bioscience, Barcelona, Spain). 
The protein sample was loaded onto the FPLC coupled 
with a Superdex 75 size exclusion column pre-
equilibrated with buffer HEPES buffer (pH 7.0). The pro-
teins were eluted with the same buffer at a flow rate of 1 
ml min-1. Fractions with hydrolytic activity were pooled, 
concentrated, and dialyzed against HEPES buffer (pH 
7.0), as before. Throughout the purification protocol the 
fractions were analyzed by SDS-polyacrylamide gel elec-
trophoresis (SDS-PAGE) on 12 % gels, in a Mini 
PROTEAN electrophoresis system (Bio-Rad),31 in which 
the proteins were stained with Coomassie brilliant blue 
(Protoblue Safe, National Diagnostics, GA, USA), and for 
hydrolytic activity using p-nitrophenyl propionate (pNPP) 
as described below. The protein concentration was de-
termined according to Bradford with bovine serum albu-
min as the standard.32 
Purity was assessed as >99% by SDS-PAGE, Matrix-
Assisted Laser Desorption/Ionization-Time-Of-
Flight/Time-Of-Flight (MALDI-TOF/TOF) and other 
complementary techniques (see Supporting Results).  
Ester bond hydrolysis activity assessment: sub-
strate profiling tests with 96 esters. Hydrolytic activity 
was assayed at 550 nm using structurally diverse esters in 
384-well plates as previously described.30,33 All chemicals 
used were of the purest grade available. Briefly, before an 
assay, a concentrated ester stock solution was prepared in 
a 96-well plate by dissolving each of the 96 esters at a 
concentration of 25 mg ml-1 in acetonitrile or dimethyl 
sulfoxide (DMSO), depending on its solubility. Stock 
solutions were prepared immediately prior to use and 
maintained in a 96-deep-well plate at 4 °C.  
The assays were conducted according to the following 
steps. First, a 384-well plate (Molecular Devices, LLC, CA, 
USA) was filled with 20 µl of 5 mM N-(2-
hydroxyethyl)piperazine-N’-(3-propanesulfonic acid 
(EPPS) buffer, pH 8.0, using a QFill3 microplate filler 
(Molecular Devices, LLC, CA, USA). Second, 2 µl of each 
ester stock solution was added to each well using a 
PRIMADIAG liquid-handling robot (EYOWN 
TECHNOLOGIES SL, Madrid, Spain). Each of the 96 es-
ters was dispensed in four replicates in each 384-plate. 
After adding the esters, the 384-well plate was filled with 
20 µl of 5 mM EPPS buffer, pH 8.0, containing 0.912 mM 
Phenol Red (used as a pH indicator) using a QFill3 micro-
plate filler. The final ester concentration in each well was 
1.14 mg ml-1, and the final concentration of Phenol Red 
was 0.45 mM. A total of 2 µl of protein solution (from a 1 
(for EH1A/EH1AB) or 16 (for EH1B) mg ml-1 stock solution in 
40 mM HEPES buffer pH 7.0) was immediately added to 
each well using an Eppendorf Repeater M4 pipette (Ep-
pendorf, Hamburg, Germany) or a PRIMADIAG liquid-
handling robot. Accordingly, the total reaction volume 
was 44 µl, with 4.5% (v/v) acetonitrile or DMSO in the 
reaction mixture. After incubation at 30 °C and 150 rpm in 
a Synergy HT Multi-Mode Microplate Reader, ester hy-
drolysis was measured spectrophotometrically in contin-
uous mode at 550 nm for a total time of 24 h. One unit 
(U) of enzyme activity was defined as the number of en-
zyme required to transform 1 µmol of substrate in 1 min 
under the assay conditions using the reported extinction 
coefficient (εPhenol red at 550 nm = 8450 M-1 cm-1).29 All val-
ues were corrected for non-enzymatic transformation. 
Kinetic measurements. For determination of kinetic 
parameters, these were calculated by simple Michaelis-
Menten kinetics.  
Kinetics experiments for pNPP were initiated by the ad-
dition of a stock solution (100 mM in acetonitrile) of 
 pNPP to 195 µl of HEPES buffer (pH 7.0) containing  EH1A, 
EH1B or EH1AB in 96-well microtiter plates. Kinetics exper-
iments for phenyl propionate were initiated by the addi-
tion of a stock solution (100 mM in acetonitrile) of phenyl 
propionate to 40 µl of 5 mM EPPS buffer pH 8.0 with 0.45 
mM Phenol Red (used as a pH indicator) containing  
EH1A, EH1B or EH1AB in 96-well microtiter plates.  For Km 
determinations, the amount of protein was 0.1, 16 and 1.4 
µg for EH1A, EH1B and EH1AB, respectively, or 100 µg for 
knockout mutants. For kcat determinations, the amount of 
pNPP and phenyl propionate was 1 and 6 mM, respective-
ly.  
In all cases, reactions were followed at 410 nm (for pNPP 
hydrolysis) or 550 nm (for phenyl propionate hydrolysis) 
by UV-vis spectrophotometry in a Synergy HT Multi-
Mode Microplate Reader. Initial rates were determined 
from linear fits of the absorbance versus time (<10% con-
version) corrected for the rate of un-catalyzed hydrolysis. 
In all cases, one unit (U) of enzyme activity was defined 
as the number of enzyme required to transform 1 µmol 
substrate in 1 min under the assay conditions using the 
reported extinction coefficient (εpNPP at 410 nm = 15200 M-1 
cm-1; εPhenol red at 550 nm = 8450 M-1 cm-1). In all cases, 
reactions (performed in triplicate) were maintained at 
30ºC. 
pH optima determinati0n. Britton and Robinson 
buffer (50 mM; pH 4.0-9.5) and pNPP (1 mM) was used for 
determining optimal pH of the enzyme variants. A total of 
2 µl of a stock solution (100 mM in acetonitrile) of pNPP 
were added to 195 µl of HEPES buffer (pH 7.0) containing  
EH1A (0.1 µg), EH1B (16 µg) or EH1AB (1.4 µg) in 96-well 
microtiter plates. The pNPP hydrolysis was monitored as 
above but at 346 nm (εpNPP at 346 nm = 4800 M-1 cm-1 re-
gardless of solution pH), in triplicates. 
Protein Energy Landscape Exploration (PELE) sim-
ulations. The initial structure was taken from the coor-
dinates of the EH1A crystal structure (PDB code: 5JD4).30 
The protonation state of titratable residues was estimated 
with the Protein Preparation Wizard (PROPKA)34 and the 
H++ server (http://biophysics.cs.vt.edu/H++) followed by 
visible inspection. At pH 8 (the pH at which the activity 
assays were performed), the catalytic triad histidine resi-
dues were δ-protonated, and the catalytic triad aspartic 
acid residues were deprotonated, resulting in the for-
mation of a histidine-serine and histidine-aspartic hydro-
gen-bonding network. The glyceryl tri-propionate struc-
ture was fully optimized with Jaguar27 in an implicit sol-
vent, and the electrostatic potential charges were com-
puted with the density functional M06 at the 6-31G* level 
of theory; ligand parameters were extracted from these 
for the classic simulations. 
We used Protein Energy Landscape Exploration (PELE) 
software to sample the binding mode of glyceryl tri-
propionate with EH1A.21 PELE is a Monte Carlo algorithm 
composed of a sequence of perturbation, relaxation, and 
Metropolis acceptance tests. In the first step, the ligand is 
subjected to random rotations and translations, while the 
protein is perturbed based on the anisotropic network 
model (ANM).27 The maximum allowed translation for the 
ligand perturbation was 1.5 Å, and the maximum rotation 
was 20°. During the protein perturbation, all atoms were 
displaced by a maximum of 0.5 Å by moving the α-
carbons following a random linear combination of the 6 
lowest eigenvectors obtained in the ANM model. The 
relaxation step included the repositioning of all amino 
acid side chains within 6 Å of the ligand and the 5 side 
chains with the highest energy increase along the previ-
ous ANM step. The relaxation stage ended with a truncat-
ed Newton minimization using the OPLS all-atom force 
field and an implicit surface-generalized Born continuum 
solvent.26 The new proposed minima were then accepted 
or rejected based on a Metropolis test. The substrate 
binding plots contained all accepted conformations for 
three 12-h simulations using 200 processors. 
Molecular dynamics.  250 ns of molecular dynamics 
(MD) simulation with DESMOND35 were performed to 
assure the enzymatic stability. After appropriate prepara-
tion of the system, as explained before, an orthorhombic 
water box with a minimum distance of 10 Å was intro-
duced. The systems were then neutralized and 150 mM 
NaCl added. Equilibration using the default protocol was 
performed followed by 20 ns NPT simulation at 300 K and 
1 atm with the OPLS-2005 force field. The temperature 
was regulated with the Nosé-Hoover chain thermostat 
while the pressure was controlled by the Martyna−artynae 
was cbarostat with isotropic coupling and a relaxation 
time of 2.0 ps.  
Peptide mass fingerprinting by Matrix-Assisted La-
ser Desorption/Ionization-Time-Of-Flight/Time-Of-
Flight (MALDI-TOF/TOF). Before MALDI-TOF/TOF 
analysis in-solution, protein digestion was performed.36 
Briefly, 20 µg of protein samples (5 mg ml-1 in 40 mM 
HEPES buffer pH 7.0) were diluted and denatured in 20 µl 
7 M urea/2 M thiourea/100 mM triethylammonium bicar-
bonate (TEAB), pH 7.5, reduced with 2 µl of 50 mM tris(2-
carboxyethyl) phosphine (TCEP, AB SCIEX), pH 8.0, at 
37°C for 60 min, followed by addition of 2 µl of 200 mM 
cysteine-blocking reagent (methyl methanethiosulfonate 
(MMTS); Pierce, Appleton, WI, USA) for 10 min at room 
temperature. Samples were diluted up to 120 µl to reduce 
guanidine concentration with 50 mM TEAB. Digestions 
were performed using sequence grade-modified trypsin 
(Promega, Alcobendas, Spain) to each sample in a ratio 
1/20 (w/w), which were then incubated at 37°C overnight 
on a shaker. Sample digestions were evaporated to dry-
ness and were cleaned-up/desalted using Stage-Tips with 
Empore 3M C18 disks (Sigma Chemical Co.; St Louis, MO, 
USA). The tryptic eluted peptides were dried by speed-
vacuum centrifugation and resuspended in 4 µl of MALDI 
solution (30% acetonitrile/15% isopropanol/0.5% tri-
fluoroacetic acid). A 0.8 µl aliquot of each peptide mix-
ture was deposited onto a 384-well OptiTOFTM Plate 
(SCIEX, Foster City, CA) and allowed to dry at room tem-
perature. A 0.8 µl aliquot of matrix solution (3 mg ml-1 α-
cyano-4-hydroxycinnamic acid in MALDI solution) was 
then deposited onto dried digest and allowed to dry at 
room temperature.  
 For MALDI-TOF/TOF analysis, samples were automati-
cally acquired in an ABi 4800 MALDI TOF/TOF mass 
spectrometer (SCIEX, Foster City, CA) in positive ion 
reflector mode (the ion acceleration voltage was 25 kV to 
MS acquisition and 2 kV to MSMS) and the obtained 
spectra were stored into the ABi 4000 Series Explorer 
Spot Set Manager. PMF and MSMS fragment ion spectra 
were smoothed and corrected to zero baseline using rou-
tines embedded in ABi 4000 Series Explorer Software 
v3.6. Each PMF spectrum was internally calibrated with 
the mass signals of trypsin autolysis ions to reach a typical 
mass measurement accuracy of <25 ppm. Known trypsin 
and keratin mass signals, as well as potential sodium and 
potassium adducts (+21 Da and +39 Da) were removed 
from the peak list. To submit the combined PMF and 
MS/MS data to MASCOT software v.2.6.0 (Matrix Science, 
London, UK), GPS Explorer v4.9 was used, searching in a 
custom protein database with the sequences encoding 
EH1A, EH1B and EH1AB. The following search parameters 
were used: enzyme, trypsin; allowed missed cleavages, 1; 
methylthiolation cysteine as fixed modification by the 
treatment with MMTS; variable modifications, oxidation 
of methionine; mass tolerance for precursors was set to ± 
50 ppm and for MS/MS fragment ions to ± 0.3 Da. The 
confidence interval for protein identification was set to ≥  
95% (p < 0.05) and only peptides with an individual ion 
score above the identity threshold were considered cor-
rectly identified. 
Estimation of molecular mass by MALDI-TOF/TOF. 
Protein samples were diluted at 1:1 ratio (v/v) with matrix 
solution (50% saturated sinapinic acid in 70% aqueous 
acetonitrile and 0.1% trifluoroacetic acid). A 1.0 µl aliquot 
of this mixture was manually deposited onto a 386-well 
OptiTOFTM Plate (ABSciex, Framingham, MA, USA) and 
allowed to dry at room temperature. For MALDI-
TOF/TOF analysis, samples were automatically acquired 
in an ABi 4800 MALDI TOF/TOF mass spectrometer 
(SCIEX, Foster City, CA) in positive ion linear mode (the 
ion acceleration voltage was 25 kV for MS acquisition). 
The detection mass range was set between 1,500 and 
80,000 m/z. 
 
RESULTS AND DISCUSSION 
Model ester hydrolase for this study. We chose a ser-
ine ester hydrolase, herein referred to as EH1A, with a 
typical α/β hydrolase fold as a model. In a recent study, it 
was identified as the most promiscuous ester hydrolase 
among a total of 147 when tested with a set of 96 chemi-
cally and structurally different esters (Supporting Table 
S1).30 EH1A was isolated from the metagenomic DNA of 
microbial communities inhabiting a karstic lake,29 and its 
structure was recently solved (PDB code 5JD4).30 The 
active site is formed by a catalytic triad formed by Ser161, 
Asp256 and His286 (Figure 1) and an oxyanion hole 
formed by Gly88, Gly89 and Gly90.30 This active site sup-
ports the hydrolysis of a broad range of 72 esters (Figure 
2, inset), with vinyl butyrate and phenyl propionate serv-
ing as best substrates (Figure 2). 
 
 
Figure 1. The relative position of the two active sites, with 
their catalytic triads. Original EH1A catalytic triad and 
oxyanion hole are shown in green and the designed EH1B 
catalytic triad and oxyanion hole in yellow.  
 
PELE simulations for locating an extra binding 
pocket. Using the PELE software, which allows mapping 
ligand diffusion and binding,21-25 we performed an explo-
ration of EH1A with glyceryl tri-propionate, a ligand with 
high activity in multiple ester hydrolases, including EH1A 
(~62000 ± 7400 U g-1; Figure 2), and appropriately sized 
for binding into defined cavities. The rationale was to 
identify (alternative) potential binding sites to accommo-
date a new active site (Figure 3). PELE simulations re-
vealed a potential second binding site located ~13 Å from 
the native catalytic position at Ser161 (Figure 4a). This 
second site (Figure 4b) already contains a serine residue 
(Ser211). Thus, we computationally designed additional 
mutations, adding Asp and His residues to build a proper 
catalytic triad, taking special care of distances between 
the residues and substrate accommodation. PELE results 
for the Glu25Asp and Leu214His double mutant revealed 
good enzyme-substrate interaction energies (Supporting 
Figure S1) and a suitable catalytic position for the glyceryl 
tri-propionate substrate. Figure 4 summarizes the catalyt-
ic triad environment of the newly introduced active site 
compared to the wild type. In addition, our results show 
that residues Gly207, Tyr208 and Phe209 act as a potential 
oxyanion hole, a key element in ester hydrolase catalysis 
(Figure 4b). Moreover, extensive MD simulations indicate 
proper stabilization of the double mutant (Supporting 
Figure S2). 
 
  
Figure 2. Substrate spectra of EH1 variants. The 72 out 96 esters for which activity was detected are listed on the right 
side panel, with indication of substrates being converted by each of the 3 variants. The ID code representing each EH 
variant is color coded. On the left main panel the relative activity (%) for each ester referred to the best substrate is indi-
cated, with specific activity (U g-1) and standard deviation (triplicates) indicated in the bars. Abbreviations as follows: 
E(R/S)CHB: ethyl (R/S)-(+)-4-chloro-3-hydroxybutyrate; BFPME: benzoic acid, 4-formyl-, phenylmethyl ester; BHPP: 
benzyl (R)-(+)-2-hydroxy-3-phenylpropionate. The activity protocol established and used to identify the esters hydrolyzed 
by each variant was based on a 550-nm follow-up pH indicator assay at pH 8.0 and 30 °C (see Experimental section). 
  
Figure 3. Molecular modeling protocol used for adding a second catalytic active site: i) Complete surface exploration with 
the probe ligand (gliceryl tri-propionate); ii) Alternative binding site location; iii) Substrate placement simulations (local 
refinement on the new site) with mutations. 
 
Figure 4. Catalytic position adopted by ethyl hexanoate (EHO) in the wild type active site (a) and in the Glu25Asp and 
Leu214His double mutant (b). Along with the substrate, the catalytic triad and the oxyanion hole residue are shown; main 
catalytic distances are underlined in angstroms. 
 
Converting the binding pocket into a functional 
catalytic site by site-directed mutagenesis. By using 
site-directed mutagenesis and with the above considera-
tions, an enzyme variant with the new presumptive active 
site and an inactive original site was designed to deter-
mine whether the extra active site was, per se, functional. 
We introduced Glu25Asp, Leu214His and Ser161Ala substi-
tutions, so that this variant, named EH1B, would presum-
ably employ a new catalytic triad (Ser211, Asp25 and 
His214) with Ser211 as the nucleophile and a new oxyanion 
hole (Gly207, Tyr208 and Phe209). The corresponding 
gene was cloned, and the His6-tagged protein was ex-
pressed and purified by Ni-NTA affinity and size-
exclusion chromatography (Supporting Figure S3 and 
Table S2). A number of control experiments were per-
formed to ensure the purity and identity of the EH1B pro-
tein (Supporting Figures S3-S8). These analyses were also 
performed with purified EH1A and other variant (see be-
low). With the sensitivity allowing MALDI-TOF/TOF and 
other complementary techniques (see Supporting Re-
sults), we can conclude that there is no contamination 
and that the purity of the EH1B (as well as EH1A and fur-
ther variant EH1AB) was higher than 99%. The introduced 
mutations were confirmed in all cases by sequencing of 
the corresponding gene and by peptide mass fingerprint-
ing by MALDI-TOF/TOF of purified proteins (for details 
see Supporting Results, and Figures S5 and S6). 
Once the purity and nature of EH1B was confirmed, its 
hydrolytic activity was evaluated against the set of 96 
esters as for the wild-type ester hydrolase (see Experi-
mental section). We found that EH1B with the new active 
site showed not only measurable activity but also cata-
lyzed reactions with 24 different substrates (Figure 2), 
including cyclohexyl butyrate and the large aromatic ester 
benzoic acid, 4-formyl-, phenylmethyl ester, which are 
rarely hydrolyzed by many native ester hydrolases (Figure 
5; esters ID nr. 59 and 67).30 Note that in EH1B the original 
active site (Ser161) was silenced by mutating it by Ala, 
mutation per se found to completely abolish the activity 
of the original active site (Supporting Figure S9D). Thus, 
the capacity of EH1B to convert these 24 esters could be 
unambiguously assigned to the new active site.  
  
 
 
Figure 5. Clustering of the substrate range of EH1 variants within them and in comparison with those of other serine ester 
hydrolases. A total of 107 ester hydrolases, including the commercial preparations CalA and CalB from Pseudozyma 
aphidis, formerly Candida antarctica, are included. The data corresponding to each EH variant is color coded. This figure 
is created from data previously reported30 and data herein obtained for EH1 variants (see Experimental section). The list of 
the esters tested is shown on the left side (full name of the esters from nr. 1 to 89 is given in Supporting Table S4). The ID 
code representing each ester-hydrolase is given at the bottom. Each hydrolase is named based on the code ‘EH’, which 
means Ester Hydrolase, followed by an arbitrary number. The number in brackets indicates the number of esters hydro-
lyzed by each enzyme. The Figure was created with the R language console, as described previously,30 using a binomial 
table with information about the activity/inactivity (1/0) of the analyzed enzymes against the 96 substrates as a starting 
point. 
 
To evaluate the catalytic potential of the newly intro-
duced active site, we compared the number of esters be-
ing hydrolyzed with that of the wild-type protein (EH1A), 
144 naturally occurring ester hydrolases and two commer-
cial preparations tested against the same set of 96 esters.30 
As shown in Figure 6, we observed that EH1B had a re-
stricted substrate spectrum (24 esters) compared to EH1A 
(72 esters), the most promiscuous ester hydrolase among 
those examined, but it was broader than that of the other 
hundred native ester hydrolases. The ester hydrolase with 
the new active site designed herein would fall into the 
category of ester hydrolases with moderate substrate 
promiscuity, thus suggesting the hydrolytic potential of 
the newly introduced active site in terms of the substrate 
spectrum. 
We further evaluated whether EH1B showed different 
substrate preferences compared to EH1A. We considered 
only those 24 substrates converted by both variants (Fig-
ure 2) and calculated the relative activity for each. As 
shown in Figure 2, distinct profiles were observed that 
highlight the difference in binding capacity for each of 
the catalytic environments. As an example, the new active 
site (EH1B) showed a higher relative preference for the 
hydrolysis of methyl-, propyl- and ethyl-hexanoate com-
pared to the native site (EH1A). The difference in substrate 
binding and preference between the new (EH1B) and wild 
type (EH1A) active sites was also noticeably when compar-
ing their capacity to hydrolyze phenyl propionate and 
pNPP (Supporting Figure S9 and Table S3). Thus, in term 
of kcat EH1B preferred phenyl propionate over pNPP (5.7-
fold), whereas EH1A slightly preferred pNPP (1.4-fold). A 
 local refinement simulation with PELE revealed that the 
changes in preference for ethyl-hexanoate correlate with 
substrate placement. In particular, the difference in num-
ber of catalytic events in both sites, which define the 
poses where the substrate is readily placed for catalysis, is 
significantly reduced for ethyl-hexanoate, when com-
pared to one of the substrates with maximum activity, 
phenyl propionate (Figure 7). Thus, differences in sub-
strate profile may be due to distinct active site architec-
tures (Figures 1 and 4). Additionally, there are different 
active site effective volumes (the active site cavity volume 
corrected by the relative solvent accessible surface area 
(SASA) of the catalytic triad) for the EH1B active site (82.2 
Å3) and the EH1A active site (167.7 Å3). This volume has 
been recently correlated with changes in substrate prom-
iscuity in ester hydrolases.30 
 
 
Figure 6. Comparison of the substrate range and catalytic 
performance of EH1 variants and other reported ester 
hydrolases. This figure is created from data previously 
reported30 and data herein reported for EH1 variants (see 
Figures 2 and 5). The main figure represents the number 
of substrates hydrolyzed by each EH1 variant compared to 
that of other 146 serine ester hydrolases that included the 
commercial preparations CalA and CalB.30 The inset rep-
resents the specific activity against glyceryl tri-butyrate of 
the EH1 variants and other 225 reported ester hydrolases 
(that included the 146 previously mentioned30 and 79 
reported elsewhere). 
 
Finally, we compared the hydrolytic rate of EH1B with 
that of EH1A and 225 previously reported ester hydrolases. 
We chose glyceryl tri-butyrate as a representative ester 
substrate because its specific activity values are common-
ly reported. As shown in Figure 2, the activity (7.3 ± 0.1 U 
g-1) might seem moderate compared to that of EH1A (5722 
± 159 U g-1). This was also proven by calculating the 
kcat/KM for phenyl propionate and pNPP, which was also 
found as a substrate (see Supporting Figure S9 and Table 
S3). Based on the modeled structure (Figure 4), the de-
signed side chains were nearby but not quite in the typi-
cal orientation for the catalytic triad, which may explain 
why catalysis was less effective for EH1B compared to 
EH1A. It is well known that catalytic triads in serine ester 
hydrolases require a precise relative orientation of the 
Ser-Asp-His side chains.11 Whatever the difference with 
EH1A, we observed that the specific activity of EH1B is 
comparable to or higher than that of 93 previously report-
ed native ester hydrolases that showed either low (≤ 6.8 U 
g-1) or no (near zero) capacity to hydrolyze this substrate 
(about 70 esterases) (Figure 6 inset). The other reported 
132 esterases were found far more active for the target 
substrate. Together, we can conclude that, at least for the 
hydrolysis of glyceryl tri-butyrate, the designed active site 
albeit being characterized by low catalytic activity, is as 
active as those of many natural hydrolases, but still not 
competitive with those of most esterases. 
 
 
Figure 7. Number of catalytic events found in EH1A and 
EH1B catalytic sites along PELE simulations for ethyl hex-
anoate (EHO) and phenyl propionate (PPT). A catalytic 
event was defined when the main catalytic distances: 
ligand-Ser, Ser-His, and His-Asp, are lower than 3.5 ang-
stroms. All simulations include the same sampling effort. 
 
We found that single Ser211Ala, as well as Asp25Gln or 
His214Phe, substitutions in EH1B completely arrested the 
activity for all 96 chemically and structurally different 
esters examined in this study (Supporting Table S2), that 
included the 24 different esters hydrolyzed by EH1B (see 
Figure 2), and pNPP (see Supporting Results and Figures 
S9 and S10). This unambiguously confirms that they are 
the functional groups supporting catalysis in the new 
active site, which is constituted by a catalytic triad, and 
not a diad or a histidine. Altogether, these data demon-
strated that it is plausible to use molecular modeling to 
find a potential extra binding pocket in a serine ester 
hydrolase that can be turned into a catalytic site. This site 
compares in terms of substrate spectra and catalytic activ-
ity with those from many other reported native ester 
hydrolases. It is difficult to make a statement whether the 
substrate spectrum of the newly introduced active site is 
comparable to, or is higher than that in the variants de-
signed de novo by computational tools previously de-
 scribed.10-12,14,16 This is because these variants were only 
tested with a restricted set of p-nitrophenyl esters, sub-
strates that are more easily hydrolyzed compared to the 
esters tested herein (Figure 2). It is clear though that, at 
least, EH1B is capable of pNPP hydrolysis with a kcat/KM of 
16.4 M-1s-1 (Supporting Figure S9 and Table S3), a value 
within the range or lower than that reported for other 
constructs using related substrates (kcat/KM from 18 to 309 
M-1s-1).  
Design and characterization of a serine ester hy-
drolase with two reactive groups. An enzyme variant 
with the two active sites (the native and the newly identi-
fied) was created to prove that an enzyme with two hy-
drolytic active sites is functional. This mutant, named 
EH1AB, was created by incorporating the Glu25Asp and 
Leu214His substitutions into the wild-type sequence. This 
two-active-site variant would likely employ Ser211 and 
Ser161 as nucleophiles (Figure 1). The corresponding gene 
was cloned, and the protein was expressed, purified (Sup-
porting Figure S3 and Table S2) and characterized as de-
scribed above. 
The analysis of the variant EH1AB confirmed its ability to 
hydrolyze all 72 esters converted by EH1A (Figure 2). Thus, 
EH1AB, as the native EH1A, could be classified as an ester 
hydrolase with prominent substrate promiscuity (Figures 
5 and 6). Because EH1A, due to its promiscuous behavior, 
converted all esters hydrolyzed by EH1B, we could not 
examine the effects of cooperativity for expanding the 
substrate spectra because of the presence of two different 
active sites in EH1AB. We further observed that EH1AB does 
show overall a substrate preference similar to that of EH1A 
(Figure 2), although in some cases, the potential of the 
newly introduced active site to increasing the preference 
for a number of esters, such as methyl-, propyl- and ethyl-
hexanoate, was noticed. Also, EH1AB preferred phenyl 
propionate over pNPP (1.3-fold), whereas EH1A slightly 
preferred pNPP (1.4-fold) (Supporting Table S3). This may 
be a consequence of a higher preference of the second 
active site for phenyl propionate over pNPP. 
The specific activity of EH1AB for all accepted esters was 
lower than that observed for EH1A but higher than that for 
EH1B (Figure 2). As example, using glyceryl tri-butyrate, 
its activity (597 ± 7 U g-1) was 10-fold lower than that of 
EH1A and 81-fold higher than that of EH1B. These differ-
ences were also observed when calculating the kcat/KM for 
phenyl propionate and pNPP (see Supporting Figure S9 
and Table S3). The change in activity with respect EH1A 
could be explained by the decrease in substrate popula-
tion for the main active site observed when introducing 
the mutants (Supporting Figures S1a and b). Visual in-
spection of the models and energies (Supporting Figure 
S1b) show a larger connection between the two sites, 
induced by changes in the hydrophobic packing (Leu24, 
Phe218, Leu24 and Trp217) after introducing His214. The 
alpha helix harboring the Leu214His mutation forms one 
face of the native active site, which slightly perturbs the 
main site. Whatever the catalytic activity level of the 
EH1AB variant compared to the native enzyme, its activity 
is significantly higher than that observed for 163 naturally 
occurring ester hydrolases (Figure 6, inset). 
The consequences of the presence of two active sites 
were visible in KM Michaelis-Menten (Supporting Figure 
S9 and Table S3) and pH optima (Supporting Figure S11) 
curves. Thus, the KM progress curve for EH1AB displays a 
sigmoidal plot of the initial reaction rate versus substrate 
concentration (for both pNPP and phenyl propionate), 
rather than the hyperbolic plots observed for EH1A and 
EH1B. This situation is typically found in allosteric en-
zymes, where the binding of substrates occurs in several 
active sites in the same enzyme molecule,37 a situation 
that may most likely occurs in EH1AB. We also observed 
that EH1AB displays an optimum pH profile distinct (nar-
rower) to those of EH1A (which showed the broader 
range) and EH1B (see Supporting Results), which also 
differ between them (Supporting Figure S11). Subsequent 
investigation of the reasons that explain these differences 
will be needed.  
We found that a combination of Ser211Ala/Ser161Ala, as 
well as Asp25Gln/Asp256Gln or His214Phe/His286Phe, 
substitutions in EH1AB completely arrested the activity of 
all 96 esters tested in this study, including the 72 esters 
converted by EH1AB, as well as pNPP (see Supporting Re-
sults and Figures S9 and S10), unambiguously confirming 
their role in catalysis.  
Altogether, these data unambiguously demonstrated 
that two different active sites can functionally and effi-
ciently co-exist in a single serine ester hydrolase. Howev-
er, we did not identify a single specific advantage of this 
engineered ester hydrolase with two active sites, albeit we 
found that properties such as substrate binding and the 
optimum pH were altered. We hypothesized why the 
engineered enzyme had lower performance. One of the 
mutations needed to introduce the new active site most 
likely slightly perturbs the native catalytic triad arrange-
ment, which has negative consequences for the activity 
phenotype of the engineered mutant. Locating an extra 
binding pocket in positions not disturbing the original 
pocket and converting it into a catalytic site could solve 
this issue. In terms of substrate spectra, we should again 
highlight that EH1A already contains an active site capable 
of hydrolyzing a prominent number of esters, which is 
significantly higher than for the other 146 natural ester 
hydrolases, including the best commercial prototypes 
such as CalB (Figure 6).30 Therefore, the probability of 
designing an active site capable of converting an addi-
tional set of esters compared to EH1A may be low. To 
unambiguously prove the advantage of introducing two 
active sites for expanding the substrate range, one should 
start with an ester hydrolase with a smaller substrate 
range and insert an extract active with different specificity 
or selectivity, which is actually being undertaken.  
 
CONCLUSION 
Is it possible to create enzymes with more than one ac-
tive site? This idea, which has never been successfully 
attempted, was the starting point of the present study. 
 Our work describes, for first time to the best of our 
knowledge, a neat proof-of-concept demonstration of the 
use of computational approaches to discover in an ester 
hydrolase already containing a native catalytic site, a 
novel binding site where a second catalytic site can be 
successfully introduced to generate a protein with two 
functional active sites for ester hydrolysis. Both active 
sites were structurally and catalytically different. We did 
not only prove that introducing extra functional groups 
into a catalytic serine ester hydrolase is plausible, but also 
examined the catalytic potential of the resulting variant as 
compared to the target ester hydrolase and other reported 
native ester hydrolases. We confirmed the catalytic po-
tential of the newly introduced active site as an individual 
catalytic entity or when combined with the native active 
site in the same polypeptide. We would like to highlight 
that a number of control experiments and analytics were 
performed to support our assertions and to ensure the 
reported catalytic activity for the de novo designed active 
site was not due to a contaminant (for details see Sup-
porting Results Section).  
Can every ester hydrolase be evolved for multiple reac-
tive groups? Possibly not, as introducing multiple catalyt-
ic environments would depend on the possibility of find-
ing an extra binding site in an enzyme of a size large 
enough to bind into defined cavities. Also, if found, it may 
not be turned into a catalytic active site after introducing 
the appropriate mutations because catalysis requires 
amino acids at appropriate distances and angles.11 Extend-
ing the analysis to other ester hydrolases and enzyme 
scaffolds will help to clarify whether the possibility to 
introduce extra catalytic sites is fortuitous or could be 
reproducible and to what extent can it happen.  
The scientific and economic benefits of introducing 
multiple active sites into an enzyme are enormous and 
may revolutionize the fields of protein design and enzy-
mology. Thus, converting binding pockets into extra cata-
lytic active sites with different active site cavity volumes, 
accessible surface areas and distances and angles between 
amino acids participating in the reactions compared to 
the native binding pockets will open novel catalytic op-
portunities for a given enzyme. These opportunities will 
come from the presence of different catalytic environ-
ments in the same polypeptide. Creating enzymes with 
multiple reactive groups may improve the substrate con-
version range of enzymes otherwise containing only one 
active site, increase the competitiveness of enzymes over 
heterogeneous catalytic materials containing a high num-
ber of functional groups, and open application ranges 
with consequent reductions in production costs of other 
multiple enzymes. Moreover, adding new active sites to 
an enzyme whose original/native one cannot well be im-
plemented for a particular application, but its overall 
structure has the appropriate technical requirements 
(scalability and robustness), may open new opportunities 
for a given enzyme. Such opportunities can be further 
explored through rational design and directed evolution 
focusing on residues around the new active site. Further 
studies in that direction would lay the foundation for 
streamlined and reproducible approaches for designing 
enzymes with multiple active sites. It would also promote 
new advances in a mechanistic understanding of enzy-
matic principles and the evolution of catalytic environ-
ments, particularly for revealing why certain areas in 
protein macromolecules are favored over others for in-
corporating active sites. 
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EH1AB structure with the two actives sites highlighted, in red the original active site and in blue 
the engineered one. EH1AB structure has been created with Maestro. 
 
 
